Membranous Nephropathy - 29 Studies Found
Withdrawn |
: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy : Glomerulonephritis, Membranous : 2013-01-04 :
|
Not yet recruiting |
: Study on the Therapeutic Effect of TCM Treatment for MDR MN : Idiopathic Membranous Nephropathy : 2015-11-18 : Drug: Jianpixiaozhong particles and Wuse Dietotherapy Jianpixiaozhong particles: Three packs once,bid po |
Completed |
: Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental :
: 2006-11-27 : |
Completed |
: Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome :
: 2006-08-09 : Drug: tacrolimus combined with prednisone |
Completed |
: Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy :
: 2002-12-17 : Drug: Sirolimus |
RECRUITING |
: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy : : 2024-05-14 |
NOT_YET_RECRUITING |
: REmission in Membranous Nephropathy International Trial (REMIT) : Primary Membranous Nephropathy : 2024-05-14 : Participants will receive an intravenous infusion of 1,000mg Obinutuzumab at Weeks 0, 2, 24 and 26.Prior to the administration of obinutuzum |
RECRUITING |
: A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy : Primary Membranous Nephropathy : 2024-05-14 : Participants will receive zanubrutinib once daily |
RECRUITING |
: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy : Primary Membranous Nephropathy : 2024-05-14 : Subjects will be randomly assigned in 1:1 treatment allocation ratio to receive the test and reference product. |